For the fifth consecutive year, Boehringer Ingelheim Vietnam, a biopharmaceutical company focused on research, has received recognition for its exceptional workplace.
Boehringer Ingelheim, a leading research-driven biopharmaceutical company in Việt Nam has commemorated the 15th anniversary of its animal health business in Việt Nam.
Boehringer Ingelheim unveiled a whitepaper titled “Moving towards a rabies-free Southeast Asia” at the Federation of Asian Veterinary Association (FAVA) Congress 2023 held in Kuching, Malaysia from November 3 to 5.
Boehringer Ingelheim, a global leader in animal health, has launched its new parasite treatment, NexGard Combo, for cats in Viet Nam with 300 customers.
Biopharmaceutical company Boehringer Ingelheim has signed a memorandum of understanding with the Ministry of Health’s Department of Medical Service Administration to optimise healthcare outcomes for patients.
Biopharmaceutical company Boehringer Ingelheim is strengthening its commitment to positively impact people, animals, communities, and the planet through key sustainability initiatives across ASEAN, South Korea, Australia, New Zealand (ASKAN) and Viet Nam.
Boehringer Ingelheim, one of the world’s top 20 pharmaceutical companies, has been recognised as a Top Employer across seven countries – Singapore, Malaysia, Philippines, Thailand, Viet Nam, Indonesia and South Korea in 2020 for its people-centric practices.